The costs and benefits of a prison needle and syringe program in Australia, 2025–30: a modelling study
Medical Journal of Australia · 2025
DOI: 10.5694/mja2.52640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of Australia, 2025. Verfasst von Farah Houdroge und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Burnet Institute, Melbourne, VIC. Hauptthemen laut MEDLINE: Needle-Exchange Programs, Prisons, Hepatitis C, Substance Abuse, Intravenous. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Fonds de Recherche du Québec - Santé.
Abstract (Originalsprache)
Objectives
To estimate and compare the costs and benefits of introducing a prison needle and syringe program in all Australian prisons. Study design Stochastic compartmental modelling study.
Setting
All Australian prisons, 1 January 2010 to 31 December 2030.
Intervention
Introduction of a prison needle and syringe program in all Australian prisons during 1 January 2025 – 1 January 2027, with the aim of covering 50% of people who inject drugs in prison by 1 January 2030. Main outcome measures Projected new hepatitis C virus (HCV) infections and hospitalisations with injection‐related bacterial and fungal infections in prisons, with and without the needle and syringe program; costs of the program; savings in treatment costs for HCV and injection‐related bacterial and fungal infections; benefit–cost ratio of the program.
Results
In the base scenario (no prison needle and syringe program), the projected number of new HCV infections during 2025–2030 was 2932 (uncertainty interval [UI], 2394–3507) and the projected number of hospitalisations with injection‐related bacterial and fungal infections was 3110 (UI, 2596–3654). With the prison needle and syringe program, it was projected that 894 (UI 880–912) new HCV infections (30%; UI, 26–37%) and 522 (UI, 509–532) hospitalisations with injection‐related bacterial and fungal infections (17%; UI, 15–20%) would be averted; the incidence of new HCV infections would be reduced from 3.1 (UI, 2.5–3.7) to 1.3 (UI, 1.0–1.7) per 100 person‐years among people who inject drugs in prison. The estimated cost of the program was $12.2 million (UI, $7.6–22.2 million), and the saved care costs for HCV and injection‐related infections were $31.7 million (UI, $29.3–34.6 million), yielding a benefit–cost ratio of 2.6 (UI, 1.4–4.1). The benefit–cost ratio was also greater than one for scenarios in which the assumptions and base values for several parameters were varied.
Conclusions
Each dollar spent on a needle and syringe program in Australian prisons could save $2.60 in treatment costs for HCV and other injection‐related infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Burnet Institute, Melbourne, VIC.
- National Drug Research Institute, Perth, WA.
- McGill University Health Centre, Montreal, Canada.
- Centre for Outcomes Research and Evaluation Research, Institute of the McGill University Health Centre, Montreal, Canada.
- St Vincent's Hospital Melbourne, Melbourne, VIC.
- The Kirby Institute, University of New South Wales, Sydney, NSW.
ORCID-Profile: Farah Houdroge, Rebecca J Winter, Joanne Carson
Förderung
- National Health and Medical Research Council
- Fonds de Recherche du Québec - Santé
Zitieren
APA
Houdroge, F., Colledge-Frisby, S., Kronfli, N., Winter, R. J., Carson, J., Stoove, M., & Scott, N. (2025). The costs and benefits of a prison needle and syringe program in Australia, 2025–30: a modelling study. Medical Journal of Australia. https://doi.org/10.5694/mja2.52640
Vancouver
Houdroge F, Colledge-Frisby S, Kronfli N, Winter RJ, Carson J, Stoove M, et al. The costs and benefits of a prison needle and syringe program in Australia, 2025–30: a modelling study. Medical Journal of Australia. 2025. doi:10.5694/mja2.52640
BibTeX
@article{Houdroge2025,
author = {Houdroge, Farah and Colledge-Frisby, Samantha and Kronfli, Nadine and Winter, Rebecca J and Carson, Joanne and Stoove, Mark and Scott, Nick},
title = {The costs and benefits of a prison needle and syringe program in Australia, 2025–30: a modelling study},
journal = {Medical Journal of Australia},
year = {2025},
doi = {10.5694/mja2.52640}
}
EUVIMED